АНТИВИРУСНЫЙ ПОТЕНЦИАЛ КУРКУМЫ ДЛИННОЙ (CURCUMA LONGA L.)

Авторы

  • Ю.А. Смирнов ФГБУ «ФНИЦ эпидемиологии и микробиологии им. Н.Ф. Гамалеи» МЗ РФ (г. Москва)

Ключевые слова:

куркума длинная, куркумин, антивирусное действие, вирусы

Аннотация

Куркума длинная (Curcuma longa L.) и её биологически активные вещества куркуминоиды обладают плейотропной активностью, включая противовоспалительную, антиоксидантную, противоопухолевую, антибактериальную и антивирусную активность. Многочисленные исследования показали, что антивирусная активность экстрактов корневища куркумы и куркуминоидов обладает широким спектром биологических и фармакологических свойств в отношении различных вирусов, таких как вирус гриппа, вирусы гепатита В и С, вирус иммунодефицита человека и др. Механизмы антивирусного действия куркумина состоят либо в прямом вмешательстве в вирусную репродукцию, либо в подавлении клеточных сигнальных путей, необходимых для вирусной репликации. В настоящем обзоре обобщены современные данные и перспективы использования антивирусной активности куркумина.

Биография автора

Ю.А. Смирнов, ФГБУ «ФНИЦ эпидемиологии и микробиологии им. Н.Ф. Гамалеи» МЗ РФ (г. Москва)

Д.м.н., профессор, ведущий научный сотрудник лаборатории онтогенеза вирусов.

Библиографические ссылки

Большой энциклопедический словарь лекарственных растений. – СПб.: Спец Лит., 2015. – 296 с.

Золотые наночастицы: синтез, свойства, биомедицинское применение / П.М. Бычковский, А.А. Кладиев, С.О. Соломевич, С.Ю. Щеголев // Российский биотерапевтический журнал. – 2011. – №3. – С.37–46.

Медицинская вирусология. – М.: МИА, 2008. – С. 21.

Панавир в лечении вирусных инфекций (Сборник под ред. акад. РАМН, В.И. Сергиенко). – М.: 2005. – 5 с.

Подходы к антивирусной фитотерапии / Ю.А. Смирнов, Т.Л. Киселева, Ю.А. Смирнова, А.А. Карпеев // Традиционная медицина. – 2009. – №2(17). – С.47–59.

Смирнов, Ю.А. Подходы к фитотерапии ВИЧ-инфекции / Ю.А. Смирнов, Н.Н. Носик, Д.Н. Носик // Традиционная медицина. – 2017. – 4(51). – С.26–35.

Соловьёва, Н.Л. Биодоступность куркумина и методы её повышения. / Н.Л. Соловьёва, М.С. Сокуренко, О.А. Зырянов // Разработка и регистрация лекарственных средств. – 2018. – №3(24). – С.46–53.

Ali, A. Curcumin inhibits HIV-1 by promoting Tat protein degradation./ A. Ali, A.C. Banerjea // Scientific Reports. – 2016; 6, 27539:1–9.

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells / C.C. Anggakusuma, L.M. Colpitts, H. Schang [et al.] // Gut. – 2014; 63 (7):1137–1149.

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/ nonhistone proteins and histone acetyltransferase-dependent chromatin transcription / K. Balasubramanyam, R.A. Varier, M. Altaf [et al.] // J. Biol. Chem. – 2004; 279:51163–51171.

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat / S. Barthelemy, L. Vergnes, L. Moynier [et al.] // Res. Virol. – 1998; 149: 43–52.

Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2 / K.Z. Bourne, N. Bourne, S.F. Reising, L.R. Stanberry // Antiviral Research. – 1999; 42(3):219–226.

The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis / G.R. Campbell, E. Pasquier, J. Watkins [et al.] // J. Biol. Chem. – 2004; 279:48197–48204.

Curcumin inhibits influenza virus infection and haemagglutination activity / D.-Y. Chen, J.-H. Shien, L. Tiley [et al.] // Food Chemistry. – 2010; 119 (4):1346–1351.

Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT / M.-H. Chen, M.-Y. Lee, J.-J. Chuang [et al.] // Int. J. Mol. Med. – 2012; 30:1021–1028.

Inhibition of enveloped viruses infectivity by curcumin / T.Y. Chen, D.Y. Chen, H.W. Wen [et al.] // PLoS ONE. – 2013; 8 (5): e62482.

??kr?k??, S. Biological activity of curcuminoids isolated from Curcuma longa./ S. ??kr?k??, E. Mozioglu, H. Y?lmaz // Records of Natural Products. – 2008; 2 (1): 19–24.

Inhibition of curcumin on influenza A virus infection and influenza pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-?B pathways / J. Dai, L. Gu, Y. Su [et al.] // Int. Immunopharmacol. – 2018; 54: 177–187.

A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells / P.R. Debata, M.R. Castellanos, J.E. Fata [et al.] // Gynecol. Oncol. – 2013; 129: 145–153.

Dutta, K. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system / K. Dutta, D. Ghosh, A. Basu // J. Neuroimmune Pharmacol. – 2009; 4: 328–337.

Fang, J.G. Thioredoxin reductase is irreversibly modified by curcumin – A novel molecular mechanism for its anticancer activity / J.G. Fang, J. Lu, A. Holmgren // J. of Biol. Chem. – 2005; 280 (26):25284–25290.

The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2 / V.H. Ferreira, A. Nazli, S.E. Dizzell [et al.] // PLoS One-2015; 10:e0124903. doi:10.1371/journal.pone.0124903.

Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia / L. Gattoc, P.M. Frew, S.N. Thomas [et al.] // Open Access J. Clin. Trials. – 2017; 9:1–10.

Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding./ K.K. Gupta, S.S. Bharne, K. Rathinasamy [et al.] // FEBS Journal. – 2006; 273 (23): 5320–5332.

Gupta, P. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors / P. Gupta, P. Garg, N. Roy //Molecular Diversity. – 2011; 15 (3):733–750.

QSAR study of curcumine derivatives as HIV-1 integrase inhibitors / P. Gupta, A. Sharma, P. Garg, N. Roy // Current Computer-Aided Drug Design. – 2013; 9 (1):141–150.

Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production / S. Han, J. Xu, X. Guo, M. Huang // Clin. Exp. Pharmacol. Physiol. – 2018; 45: 84–93.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells / M. Hergenhahn, U. Soto, A. Weninger [et al.] // Molecular Carcinogenesis. – 2002; 33 (3):137–145.

Hsing-I Huang, Inhibition of EV71 by curcumin in intestinal epithelial cells / Hsing-I Huang, Chi-Chong Chio, Jhao-Yin Lin // PLOS ONE- 2018; 13(1): 1-20. https://doi.org/10.1371/journal.pone.0191617.

Joe, B. Biological properties of curcumin-cellular and molecular mechanisms of action / B. Joe, M. Vijaykumar, B.R. Lokesh // Critical Reviews in Food Science and Nutrition. – 2004; 44 (2):97–111.

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication / H.J. Kim, H.S. Yoo, J.C. Kim [et al.] // J. Ethnopharmacol. – 2009; 124:189–196.

Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway / K. Kim, K.H. Kim, H.Y. Kim [et al.] // FEBS Lett. – 2010; 584:707–712.

Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice / J. Kim, H.-L. Ha, H.-B. Moon [et al.] // Integr. Cancer Ther. 2011; 10:168–177.

Inhibition of HIV-1 by curcumin A, a novel curcumin analog / N. Kumari, A.A. Kulkarni, X. Lin [et al.] // Drug Des. Devel. Ther. – 2015; 9:5051–5060.

Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study / B. Kunwar, A. Barik, R. Pandey, K.I. Priyadarsini // Biochim. Biophys. Acta (Gen.). – 2006; 1760: 1513–1522.

Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyl transferase activity / S.B. Kutluay, J. Doroghazi, M.E. Roemer, S.J. Triezenberg // Virology. – 2008; 373(2):239–247.

Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity / T.H. Leu, S.L. Su, Y.C. Chuang, M.C. Maa // Biochemical Pharmacology. – 2003; 66 (12):2323–2331.

Li L. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis./ L Li., F.S. Braiteh, R. Kurzrock // Cancer. – 2005; 104: 1322–1331. DOI: 10.1002/cncr.21300.

Protein phosphatase-1-targeted small molecules, iron chelators and curcumin analogs as HIV-1 antivirals / X. Lin, T. Ammosova, N. Kumari, S. Nekhai // Curr. Pharm. Des. – 2017; 23:4122–4132.

Curcumin inhibits human cytomegalovirus by downregulating heat shock protein 90 / Y. Lv, L. Gong, Z. Wang [et al.] // Molecular Medicine Reports. – 2015; 12 (3):4789–4793.

Protective effect of curcumin against cytomegalovirus infection in Balb/c mice / Y. Lv, N. Lei, D. Wang [et al.] // Environmental Toxicology and Pharmacology. – 2014; 37 (3): 1140–1147.

Computer aided screening of natural compounds targeting the E6 protein of HPV using molecular docking / S. Mamgain, P. Sharma, R. K . Pathak, M. Baunthiyal // Bioinformation. – 2015; 11: 236–242.

Mathew, D.C. Antiviral potential of curcumin / D.C. Mathew, W-L. Hsu // Journal of Functional Foods. – 2018; 40(692):699 DOI: 10.1016/j.jff.2017.12.017.

Inhibition of human immunodeficiency virus type-1 integrase by curcumin./ A. Mazumder, K. Raghavan, J. Weinstein [et al.] // Biochem. Pharmacol. – 1995; 49(8):1165–1170.

Mi?ob?dzka, J. Zur kenntnis des curcumins / J. Mi?ob?dzka, S. Kostanecki, V. Lampe // Ber. Deut. Chem. Ges. – 1910; 43:2163–2170.

Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer / A. Mishra, R. Kumar, A. Tyagi [et al.] // Ecancer medical science. – 2015; 9:525.

A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin / S.Z. Moghadamtousi, H.A. Kadir, P. Hassandarvish [et al.] // Biomed Res Int. – 2014; 2014: 186864. doi: 10.1155/2014/186864.

Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding / B.C. Mounce, T. Cesaro, L. Carrau [et al.] // Antiviral Res. – 2017; 142:148–157.

Celastrol inhibits Tat-mediated human HIV transcription and replication / V. Narayan, K.C. Ravindra, C. Chiaro [et al.] // Journal of Molecular Biology. – 2011; 410 (5):972–983.

Curcumin inhibits Rift Valley fever virus replication in human cells / A. Narayanan, K. Kehn-Hall, S. Senina [et al.] // Journal of Biological Chemistry. – 2012; 287 (40):33198–33214.

Newman, D.J. Natural products as sources of new drugs from 1981 to 2014 / Newman D.J., Cragg G.M. // J. Nat. Prod. – 2016;79:629–661.

Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells / K. Obata, T. Kojima, T. Masaki [ et al.] // PLoS ONE. – 2013; 8 (9):e70225.

Omosa, L.K. «Curcuma longa» in Therapeutic Potential Against Metabolic, Inflammatory, Infectious and Systemic Diseases / L.K. Omosa, J.O. Midiwo, V. Kuete // ed. Kuete V., editor. (Cambridge, MA: Academic Press;). – 2017:425–435.

Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity / J.-L. Ou, Y. Mizushina, S.-Y. Wang [et al.] // FEBS J. – 2013; 280:5829–5840.

Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro / S.L. Padilla, A. Rodriguez, M.M. Gonzales [et al.] // Archiv. of Virol. – 2014; 159 (3):573–579.

Anti-infective Properties of the Golden Spice Curcumin / D. Praditya, L. Kirchhoff, J. Br?ning [et al.] // Front Microbiol. – 2019; 10: 912: 1–18. doi: 10.3389/fmicb.2019.00912.

Priyadarsini, K.I. The Chemistry of Curcumin: From Extraction to Therapeutic Agent / K.I. Priyadarsini // Molecules. – 2014; 19: 291–212.

Ravindran, J. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? / J. Ravindran, S. Prasad, B.B. Aggarwa // AAPS Journal. – 2009; 11 (3):495–510.

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha / M.M. Rechtman, O. Har-Noy, I. Bar-Yishay [et al.] // FEBS Letters. – 2010; 584 (11):2485–2490.

Reddy, S. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase / S. Reddy, & B.B. Aggarwal // FEBS Letters. – 1994; 341:19–22.

Innovative preparation of curcumin for improved oral bioavailability / H. Sasaki, Y. Sunagawa, K. Takahashi [et al.] // Biol. Pharm. Bull. – 2011; 34(5):660–665.

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 / M. Scheffner, B.A. Werness, J. M. Huibregtse [et al.] // Cell. – 1990; 63:1129–1136.

Docking study of HIV-1 reverse transcriptase with phytochemicals / A. Seal, R. Aykkal, R.O. Babu, M. Ghosh // Bioinformation. – 2011; 5 (10): 430–439.

Setlur A.S. Herbal lead as ideal bioactive compounds against probable drug targets of Ebola virus in comparison with known chemical analogue: A computational drug discovery perspective / A.S. Setlur, S.Y. Naik, S. Skariyachan // Interdisciplinary Sciences. – 2017; 9 (2):254–277.

Immunomodulatory activities of curcumin-stabilized silver nanoparticles: efficacy as an antiretroviral therapeutic / R.K. Sharma, K. Cwiklinski, R. Aalinkeel [et al.] // Immunol. Invest. – 2017; 46:833–846.

Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication / X. Si, Y. Wang, J. Wong [et al.] //Journal of Virology. – 2007;81(7):3142–3150.

Curcumin conjugated gold nanoparticle synthesis and its bioavailability./ K. Sindhu, A. Rajaram, K.J. Sreeram, R. Rajaram // RSC Adv. – 2014; 4:1808–1814.

Structure of curcumin in complex with lipoxygenase and its significance in cancer / E. Skrzypczak-Jankun, K. Zhou, N.P. McCabe [et al.] // Intern. J. Mol. Medicine. – 2003; 12 (1):17–24.

Sordillo, P.P. Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections / P.P. Sordillo, L. Helson // In Vivo. – 2015; 29 (1):1-4.

Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes / Z. Sui, R. Salto, J. Li [et al.] // Bioorganic & Medicinal Chemistry. – 1993; 1 (6):415–422.

Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase lambda / T. Takeuchi, T. Ishidoh, H. Iijima [et al.] // Genes to Cells. – 2006; 11 (3):223–235.

Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys / S. Umar, M.A.A. Shah, M.T. Munir [et al.] // Poult. Sci. – 2016; 95 1513–1520.

Active site binding modes of curcumin in HIV-1 protease and integrase / O. Vajragupta, P. Boonchoong, G.M. Morris, A.J. Olson // Bioorganic & Medicinal Chemistry Letters. – 2005; 15(14):3364–3368.

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation / Z.-Q. Wei, Y.-H. Zhang, C.-Z. Ke [et al.] // World J. Gastroenterol. – 2017; 23:6252–6260.

Yang, X.X. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection / X.X. Yang, C.M. Li, & C.Z. Huang // Nanoscale. – 2016; 8(5):3040–3048.

Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line / K. Zandi, E. Ramedani, Mohammadi [et al.] // Natural Product Communications. – 2010; 5(12):1935–1938.

Two traditional Chinese medicines Curcumae radix and Curcumae Rhizoma: An ethnopharmacology, phytochemistry and pharmacology review / Y. Zhou, M. Xie, Y. Song [et al.] // Evidence-Based Complementary and Alternative Medicine. – 2016; 2016(3):1–30.

Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells / L. Zhu, X. Ding, D. Zhang [et al.] // Acta Virologica. – 2015; 59 (3):221–227.

Опубликован

2020-06-30

Как цитировать

Смирнов, Ю. «АНТИВИРУСНЫЙ ПОТЕНЦИАЛ КУРКУМЫ ДЛИННОЙ (CURCUMA LONGA L.)». Традиционная медицина, вып. 2(61) 2020, июнь 2020 г., сс. 12-19, http://www.tradmed.ru/index.php/tm/article/view/1507.

Выпуск

Раздел

Натуротерапия